Anticoagulation does not appear to help, and may in fact harm, patients with liver cancer and portal vein thrombosis (PVT), new research shows.
Use of anticoagulants in these patients varies from medical center to medical center and between individual physicians, according to Alan A. Weiss, MD, a gastroenterologist and clinical professor at the University of British Columbia, in Vancouver. However, the use of anticoagulants to treat patients with hepatocellular carcinoma (HCC) and PVT has never